Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The salary cost of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) president and CEO Dr. Jeremy Levin was NIS 14.7 million in 2012. His salary was NIS 5.4 million, his annual bonus was NIS 4.3 million, based on the company’s profit for the year, and the capital component (the fair value of his stock option grants) was also NIS 4.3 million. Levin has received 450,000 options exercisable at $46 per share, a price that is currently outside the money.
Help employers find you! Check out all the jobs and post your resume.
